Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead
Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead
Saluda Medical
ASX: SLD ~$500M MCAP
Saluda Medical is a biopharma company.
Company Info
Recent News
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead Saluda Medical,
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead Saluda Medical, Inc. (ASX: SLD, 'Saluda' or the
Leadership Team
Careers & Job Openings